FIGURE

Fig. 8

ID
ZDB-FIG-250909-39
Publication
Guzman et al., 2025 - B-rich colistin and B-pure colistin as novel strategies to increase the therapeutic window of polymyxin antibiotic therapy
Other Figures
All Figure Page
Back to All Figure Page
Fig. 8

Lethality and neurotoxicity evaluation of A-pure and B-pure colistin after melatonin, EGCG or curcumin pre-exposure. 2 hpf zebrafish embryos were exposed to melatonin, EGCG or curcumin for 4 h. Afterwards, solutions were changed to 5 µM of A-pure colistin or 10 µM of B-pure colistin until 72 hpf where the lethality was recorded, and the TER assay was performed. A) Percentage of accumulated lethality after A-pure colistin exposure. B) Percentage of accumulated lethality after B-pure colistin exposure. C) TER assay after A-pure colistin exposure. D) TER assay after B-pure colistin exposure. In all cases results are expressed as mean ± SEM of 3 independent experiments with 10 or 6 embryos per group for lethality or TER assay, respectively. Statistical analysis was performed using One-way ANOVA with Bonferroni’s pos-hoc test. * Indicates significant differences with the control. # indicates significant differences with the colistin group. In all cases p < 0.05 was considered for statistical differences.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.